Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla

The value of a Quality-Adjusted Life Year (QALY) used to screen medicines for inclusion in the National List of Essential Medicines (NLEM) in 2013 was 160,000 baht per QALY. Any medicines that cost less than this amount is considered to be cost-effective. However, is this figure consistent with publ

What do you think about COVID-19 vaccination certificates for international travel? This survey on COVID-19 vaccination certificates is part of a regional research study from the COVID-19 vaccination policy research and decision-support initiative in Asia (CORESIA). We would like

หลักการและเหตุผล สถานะทางสุขภาพของประชาชนถือเป็นดัชนีชี้วัดที่สำคัญในการพัฒนาประเทศและถือเป็นหน้าที่หลักของรัฐบาลในกา

This is a promising time for the advancement of evidence and use of health technology assessment (HTA) in the Philippines. The HTA unit, STEP (Sentro ng Pagsusuri ng Teknolohiyang ngkalusugan), is currently conducting three studies to support national decision-making: 1) the economic evaluatio

Yot Teerawattananon, Alia Luz* , Songyot Pilasant, Suteenoot Tangsathitkulchai, Sarocha Chootipongchaivat, Nattha Tritasavit, Inthira Yamabhai and Sripen Tantivess Abstract Background: It is very challenging for resource-limited settings to introduce universal health coverage (UHC), particular

Usa Chaikledkaew BSc(Pharm), MA, PhD*,**, Kankamon Kittrongsiri BSc(Pharm)*,** * Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand ** Health Intervention and Technology Assessment Program, Minis

A collaborative study was conducted by representatives from the Ministry of Health’s Directorate of Non – Communicable Disease (NCD) Control and the National Institute of Health Research and Development (NIHRD), the WHO Indonesia office, the WHO Southeast Asia Regional Office, and the Health Interve

My name is Vanhpheng CHANPHOTHONG, I am Laotian. I work at Institute of Research and Education Development, University of Health Sciences, Lao PDR. I was invited to come to Thailand in August 2019 to attend HITAP’s training in economic evaluation and afterwards complete an internship where we looked

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr